Eagle’s Eye View: Oral Semaglutide for Weight Loss; Anticoagulants for PAH; The ECDP on TR Evaluation and Management
In this week’s View, Dr. Eagle looks at the value of oral semaglutide for weight loss. He then explores whether anticoagulants improve survival in patients with pulmonary arterial hypertension (PAH). Finally, Dr. Eagle discusses the recent release of the ACC Expert Consensus Decision Pathway (ECDP) on tricuspid regurgitation (TR) evaluation and management.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Anticoagulation Management, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Pulmonary Hypertension and Venous Thromboembolism, Pulmonary Hypertension, Echocardiography/Ultrasound
Keywords: EaglesEyeView, Semaglutide, Glucagon-Like Peptide 1, Obesity, Weight Loss, Anticoagulants, Pulmonary Arterial Hypertension, Propensity Score, Thromboembolism, Registries, Tricuspid Valve Insufficiency, Echocardiography, Echocardiography, Transesophageal, Cardiac Catheterization
